Literature DB >> 28100905

Renal transplantation in 2016: Novel approaches to improve recipient and allograft outcomes.

Paolo Malvezzi1, Lionel Rostaing1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28100905     DOI： 10.1038/nrneph.2016.190

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.

Authors:  J O Medina Pestana; J M Grinyo; Y Vanrenterghem; T Becker; J M Campistol; S Florman; V D Garcia; N Kamar; P Lang; R C Manfro; P Massari; M D C Rial; M A Schnitzler; S Vitko; T Duan; A Block; M B Harler; A Durrbach
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

2.  Kidney Transplants from HLA-Incompatible Live Donors and Survival.

Authors:  Babak J Orandi; Robert A Montgomery; Dorry L Segev
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

3.  Belatacept and Long-Term Outcomes in Kidney Transplantation.

Authors:  Flavio Vincenti
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

4.  Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Authors:  Donald E Hricik; Richard N Formica; Peter Nickerson; David Rush; Robert L Fairchild; Emilio D Poggio; Ian W Gibson; Chris Wiebe; Kathryn Tinckam; Suphamai Bunnapradist; Milagros Samaniego-Picota; Daniel C Brennan; Bernd Schröppel; Osama Gaber; Brian Armstrong; David Ikle; Helena Diop; Nancy D Bridges; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2015-04-29       Impact factor: 10.121

Review 5.  Kidney paired donation: principles, protocols and programs.

Authors:  Paolo Ferrari; Willem Weimar; Rachel J Johnson; Wai H Lim; Kathryn J Tinckam
Journal:  Nephrol Dial Transplant       Date:  2014-10-07       Impact factor: 5.992

6.  Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

Authors:  P Gatault; N Kamar; M Büchler; C Colosio; D Bertrand; A Durrbach; L Albano; J Rivalan; Y Le Meur; M Essig; N Bouvier; C Legendre; B Moulin; A-E Heng; P-F Weestel; J Sayegh; B Charpentier; L Rostaing; E Thervet; Y Lebranchu
Journal:  Am J Transplant       Date:  2017-01-03       Impact factor: 8.086

7.  Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

Authors:  F Vincenti; C P Larsen; J Alberu; B Bresnahan; V D Garcia; J Kothari; P Lang; E Mancilla Urrea; P Massari; G Mondragon-Ramirez; R Reyes-Acevedo; K Rice; L Rostaing; S Steinberg; J Xing; M Agarwal; M B Harler; B Charpentier
Journal:  Am J Transplant       Date:  2011-10-12       Impact factor: 8.086

8.  Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study.

Authors:  R A Montgomery; B J Orandi; L Racusen; A M Jackson; J M Garonzik-Wang; T Shah; E S Woodle; C Sommerer; D Fitts; K Rockich; P Zhang; M E Uknis
Journal:  Am J Transplant       Date:  2016-06-27       Impact factor: 8.086

9.  One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.

Authors:  Bénédicte Sautenet; Gilles Blancho; Mathias Büchler; Emmanuel Morelon; Olivier Toupance; Benoit Barrou; Didier Ducloux; Valérie Chatelet; Bruno Moulin; Caroline Freguin; Marc Hazzan; Philippe Lang; Christophe Legendre; Pierre Merville; Georges Mourad; Christine Mousson; Claire Pouteil-Noble; Raj Purgus; Jean-Philippe Rerolle; Johnny Sayegh; Pierre-François Westeel; Philippe Zaoui; Hedia Boivin; Amélie Le Gouge; Yvon Lebranchu
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939
  9 in total
  3 in total

Review 1.  CD39-adenosinergic axis in renal pathophysiology and therapeutics.

Authors:  Bellamkonda K Kishore; Simon C Robson; Karen M Dwyer
Journal:  Purinergic Signal       Date:  2018-01-13       Impact factor: 3.765

2.  Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?

Authors:  Paolo Malvezzi; Thomas Jouve; Lionel Rostaing
Journal:  EBioMedicine       Date:  2018-08-07       Impact factor: 8.143

3.  Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients.

Authors:  Stanley C Jordan; Suphamai Bunnapradist; Jonathan S Bromberg; Anthony J Langone; David Hiller; James P Yee; John J Sninsky; Robert N Woodward; Arthur J Matas
Journal:  Transplant Direct       Date:  2018-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.